Chair of the NCCN Board of Directors
UT Southwestern Simmons Comprehensive Cancer Center
Golden, Colorado
John W. Sweetenham, MD, FRCP, FACP, FASCO
John W. Sweetenham, MD, FRCP, FACP, FASCO, is Adjunct Professor of Medicine and at the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern in Dallas, Texas.
He attended medical school at St. Bartholomew’s Hospital in London and trained in Oncology at the University of Southampton, United Kingdom, where he was subsequently a Senior Lecturer in Medical Oncology. He moved to the University of Colorado in 2000. He joined the Cleveland Clinic Taussig Cancer Institute and Lerner College of Medicine in November 2005. Prior to moving to UT Southwestern in April 2019, he spent six years as Senior Director of Clinical Affairs and Physician in Chief at the Huntsman Cancer Institute, University of Utah.
Dr. Sweetenham is internationally renowned for his clinical research in malignant lymphomas and the use of stem cell transplantation. He has authored more than 200 original articles, chapters, and books in this area of investigation. He has previously served as a member of the Lymphoma Working Committee of the Eastern Cooperative Oncology Group and the Lymphoma Working Group of SWOG and as Chair of the Clinical Trials Committee of Leukemia and Lymphoma Research, UK.
Dr. Sweetenham is Chair of the NCCN Board of Directors
Saturday, October 7, 2023
3:35 PM – 4:55 PM ET